Usymro 90 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
Ustekinumab
General information
Drug nameUsymro 90 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
Medicine nameUstekinumab
National drug code3005386
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug group—
OriginatorNo
Orphan drugNo
Marketing authorization
Procedure typePotrditev podatkov za CP zdravila (modro okence)
No. and date of decision/certificate1024-98/2025-3, 14. 11. 2025
Authorization validity dateUntil further notice
Marketing end date—
Application type—
Authorization/certificate holderGedeon Richter Plc.
Drug safety monitoring
Additional safety monitoringYes
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No
ATC codes
Route of administration
Route of administration name
Subkutana uporaba
Settlement data for compulsory health insurance billing
Substitute medicine
Preparation—
Valid from – to—
Clinical use data
Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo
Shortage actions
Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo
Drug status
This medicine is subject to additional safety monitoring. You can report any suspected adverse reactions yourself.
Ni podatka o razpoložljivosti zdravila
Last drug update date:9. 7. 2026